Texas House of Representatives · 89th Legislature, Regular Session
Members who authored, joint-authored, or co-sponsored this bill.
SourceLegiScan (CC BY 4.0)89R
AI summary unavailable. We’re still building out our data, so newer and more active legislation has better coverage.
Each version links to the authoritative document on capitol.texas.gov.
89R14542 SCL-D By: Shofner H.B. No. 3455 A BILL TO BE ENTITLED AN ACT relating to manufacturer disclosure requirements and liability for experimental drugs and devices. BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: SECTION 1. Subchapter E, Chapter 431, Health and Safety Code, is amended by adding Section 431.118 to read as follows: Sec. 431.118. EXPERIMENTAL DRUG OR DEVICE DISCLOSURE
REQUIREMENTS; LIABILITY. (a) In this section, "experimental drug or device" means a drug or device that: (1) is experimental or investigational; or (2) has been approved by the United States Food and Drug Administration for emergency use. (b) A manufacturer of an experimental drug or device shall provide to a purchaser of the drug or device a disclosure form that provides a consumer all information reasonably necessary for the consumer to make an informed decision on whether to use the drug or device, including possible adverse health effects of the drug or device, in a clear and coherent summary. (c) A purchaser of an experimental drug or device shall provide the disclosure form described by Subsection (b) to a person to whom the purchaser sells the drug or device. A health care provider or retailer providing or selling the drug or device to a consumer: (1) shall provide the disclosure form in person to the consumer; and (2) may provide or sell the drug or device to the consumer only if a person capable of providing informed consent for the ultimate consumer of the drug or device signs the disclosure. (d) A consumer who receives an experimental drug or device in violation of this section may bring an action against the manufacturer of the drug or device for damages arising from an adverse effect of the drug or device. (e) A prevailing claimant in an action brought under Subsection (d) may recover: (1) compensatory damages, including damages for physical and emotional pain and suffering; (2) exemplary damages; and (3) reasonable attorney's fees and costs incurred in bringing the action. SECTION 2. Section 431.118, Health and Safety Code, as added by this Act, applies only to a cause of action that accrues on or after the effective date of this Act. SECTION 3. This Act takes effect September 1, 2025.
Statewide figures for the subjects tagged on this bill, to explore on the Data map. They describe Texas — not this bill or its effects.
SourceU.S. Census Bureau (ACS) & CDC PLACESstatewide Data layer
Each subject links to other 89R bills tagged the same way.
SourceLegiScan (CC BY 4.0)
SourceTexas Legislative Council (capitol.texas.gov)89R
No recorded roll-call votes on this bill.
SourceLegiScan (CC BY 4.0)89R
SourceTexas Legislative Council (capitol.texas.gov)official bill text (capitol.texas.gov)
SourceLegiScan (CC BY 4.0)official fiscal notes & analyses (TLC)
Perch never collects comments itself — it points you to the Legislature's own hearing schedule and official public-comment channels (ADR-0007).
Official hearings & comment (capitol.texas.gov) →SourceLegiScan (CC BY 4.0)hearing schedule